Biorchestra

BIORCHESTRA is a biotechnology company developing RNA therapeutics and proprietary delivery technologies for CNS diseases. Its BDDS™ platform is designed to enable systemic delivery of oligonucleotides across the blood–brain barrier and broad distribution throughout the brain. The company is seeking global partners for its BMD-001 program in Parkinson’s disease and BMD-002 program in epilepsy, as well as partners with RNA payloads that could benefit from application of the BDDS™ platform.